Bydureon and Breastfeeding
Although animal studies have shown that Bydureon (extended-release exenatide) does pass through breast milk in rats, it is unknown whether the drug would pass through human breast milk. Because of the unknown risks, the manufacturer of the drug recommends that women avoid using Bydureon while breastfeeding.
Can Breastfeeding Women Use Bydureon?Bydureon™ (extended-release exenatide) is a prescription medication approved for treating type 2 diabetes. The manufacturer of this drug does not recommend that women use Bydureon while breastfeeding, due to the unknown risks. Therefore, you should talk with your healthcare provider before using it if you are breastfeeding or plan to start.
More Information on Bydureon and BreastfeedingIt is known that Bydureon passes through breast milk in rats, although no studies have been done to see if the same is true in humans. It is unknown if the digestive tract of infants would be able to absorb Bydureon, or whether the drug would be destroyed in the digestive tract.
Because Bydureon causes thyroid tumors in laboratory animals, the manufacturer currently advises women to avoid nursing while using this drug.
Before starting treatment, you and your healthcare provider must consider the benefits of using the drug, the benefits of breastfeeding for your baby, and the possible unknown risks of Bydureon to your baby.
Talking With Your Healthcare ProviderYou should discuss breastfeeding and Bydureon use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.